82 related articles for article (PubMed ID: 22882200)
41. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.
Charlton MR; Burns JM; Pedersen RA; Watt KD; Heimbach JK; Dierkhising RA
Gastroenterology; 2011 Oct; 141(4):1249-53. PubMed ID: 21726509
[TBL] [Abstract][Full Text] [Related]
42. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
[TBL] [Abstract][Full Text] [Related]
43. Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States.
Afzali A; Berry K; Ioannou GN
Liver Transpl; 2012 Jan; 18(1):29-37. PubMed ID: 21932374
[TBL] [Abstract][Full Text] [Related]
44. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study.
Watt KD; Pedersen RA; Kremers WK; Heimbach JK; Charlton MR
Am J Transplant; 2010 Jun; 10(6):1420-7. PubMed ID: 20486907
[TBL] [Abstract][Full Text] [Related]
45. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.
Starley BQ; Calcagno CJ; Harrison SA
Hepatology; 2010 May; 51(5):1820-32. PubMed ID: 20432259
[TBL] [Abstract][Full Text] [Related]
46. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease.
Yalamanchili K; Saadeh S; Klintmalm GB; Jennings LW; Davis GL
Liver Transpl; 2010 Apr; 16(4):431-9. PubMed ID: 20373454
[TBL] [Abstract][Full Text] [Related]
47. Recurrence of nonalcoholic fatty liver disease after liver transplantation: it is common, but does it affect outcome?
Newsome PN
Liver Transpl; 2010 Apr; 16(4):420-2. PubMed ID: 20373452
[No Abstract] [Full Text] [Related]
48. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
[TBL] [Abstract][Full Text] [Related]
49. Outcome after liver transplantation for NASH cirrhosis.
Malik SM; deVera ME; Fontes P; Shaikh O; Ahmad J
Am J Transplant; 2009 Apr; 9(4):782-93. PubMed ID: 19344467
[TBL] [Abstract][Full Text] [Related]
50. Epidemiology and natural history of NAFLD and NASH.
Ong JP; Younossi ZM
Clin Liver Dis; 2007 Feb; 11(1):1-16, vii. PubMed ID: 17544968
[TBL] [Abstract][Full Text] [Related]
51. Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients.
Solga SF; Clark JM; Alkhuraishi AR; Torbenson M; Tabesh A; Schweitzer M; Diehl AM; Magnuson TH
Surg Obes Relat Dis; 2005; 1(1):6-11. PubMed ID: 16925194
[TBL] [Abstract][Full Text] [Related]
52. The epidemiology of nonalcoholic fatty liver disease in adults.
Clark JM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
[TBL] [Abstract][Full Text] [Related]
53. Natural history of nonalcoholic steatohepatitis.
Liou I; Kowdley KV
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
[TBL] [Abstract][Full Text] [Related]
54. The natural history of nonalcoholic fatty liver disease: a population-based cohort study.
Adams LA; Lymp JF; St Sauver J; Sanderson SO; Lindor KD; Feldstein A; Angulo P
Gastroenterology; 2005 Jul; 129(1):113-21. PubMed ID: 16012941
[TBL] [Abstract][Full Text] [Related]
55. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies.
Fassio E; Alvarez E; DomÃnguez N; Landeira G; Longo C
Hepatology; 2004 Oct; 40(4):820-6. PubMed ID: 15382171
[TBL] [Abstract][Full Text] [Related]
56. Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption.
Lainé F; Bendavid C; Moirand R; Tessier S; Perrin M; Guillygomarc'h A; Guyader D; Calon E; Renault A; Brissot P; Turlin B; Deugnier Y
Hepatology; 2004 Jun; 39(6):1639-46. PubMed ID: 15185305
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.
Beymer C; Kowdley KV; Larson A; Edmonson P; Dellinger EP; Flum DR
Arch Surg; 2003 Nov; 138(11):1240-4. PubMed ID: 14609874
[TBL] [Abstract][Full Text] [Related]
58. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
Harrison SA; Torgerson S; Hayashi PH
Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
[TBL] [Abstract][Full Text] [Related]
59. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.
Hui JM; Kench JG; Chitturi S; Sud A; Farrell GC; Byth K; Hall P; Khan M; George J
Hepatology; 2003 Aug; 38(2):420-7. PubMed ID: 12883486
[TBL] [Abstract][Full Text] [Related]
60. The prevalence and etiology of elevated aminotransferase levels in the United States.
Clark JM; Brancati FL; Diehl AM
Am J Gastroenterol; 2003 May; 98(5):960-7. PubMed ID: 12809815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
